Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase 3 5Phase NA 2Phase 2/3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 15Lymphoid 15Sarcoma 2Gynecologic 2Genitourinary 2Myeloid 1Classical hematology 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Biphenotypic, Acute 1Leukemia 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

fludarabine phosphate 3Filgrastim 3Cyclophosphamide 3eltrombopag 2Radiotherapy 2Methylprednisolone 2Melphalan 2Cytarabine 2Busulfan 2Azacitidine 2Antilymphocyte Serum 2venetoclax 1tipifarnib 1cedazuridine 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Rivaroxaban 1Methotrexate 1Immunologic Techniques 1Granulocyte Colony-Stimulating Factor 1Gene Expression Profiling 1Gemtuzumab 1Etoposide 1Daunorubicin 1Darbepoetin alfa 1DNA Methylation 1Cytogenetic Analysis 1Cyclosporine 1Clofarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Methotrexate × Classical hematology × Clear all
NCT00003187 2010-02-24

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Virginia Commonwealth University

Phase 2/3 Completed
19 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡